etoposide has been researched along with fluorescein-5-isothiocyanate in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 8 (57.14) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanai, S; Koyama, Y; Miwa, M; Poltronieri, P; Uchida, K; Yokota, T | 1 |
| Jacquemin-Sablon, A; Mannone, L; Ségal-Bendirdjian, E | 1 |
| Daniel, TO; Koury, MJ; Kravtsov, VD | 1 |
| Qi, L; Sit, KH | 1 |
| Alm, K; Oredsson, SM | 1 |
| Biola, A; Marzin, D; Meintières, S; Pallardy, M | 1 |
| Cervinka, M; Rudolf, E | 1 |
| Budd, DC; Cain, K; Emsley, N; McDonald, J; Tobin, AB | 1 |
| Austin, CA; Errington, F; Leontiou, C; Tilby, MJ; Willmore, E | 1 |
| Anderson, SM; Limesand, KH; Schwertfeger, KL | 1 |
| Damrot, J; Epe, B; Fritz, G; Kaina, B; Nübel, T; Roos, WP | 1 |
| Dartsch, DC; Hennesen, J; Schonn, I | 1 |
| Dana, R; Fuchsluger, TA; Jurkunas, U; Kazlauskas, A | 1 |
| Anish, C; Bagchi, T; Jinturkar, KA; Kumar, MK; Misra, AR; Panda, AK | 1 |
14 other study(ies) available for etoposide and fluorescein-5-isothiocyanate
| Article | Year |
|---|---|
PARP cleavage in the apoptotic pathway in S2 cells from Drosophila melanogaster.
Topics: Animals; Annexins; Apoptosis; Cell Line; Cysteine Endopeptidases; Drosophila melanogaster; Enzyme Activation; Etoposide; Fluorescein-5-isothiocyanate; Hydrolysis; Mitochondria; Poly(ADP-ribose) Polymerases; Propidium; Rhodamines | 1997 |
Alteration in p53 pathway and defect in apoptosis contribute independently to cisplatin-resistance.
Topics: Animals; Annexin A5; Apoptosis; Cell Cycle; Cisplatin; Cyclin B; Cyclin B1; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA Fragmentation; Drug Resistance; Endonucleases; Enzyme Inhibitors; Etoposide; Fluorescein-5-isothiocyanate; Gene Expression Regulation, Neoplastic; Mice; Nuclear Proteins; Staurosporine; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 1998 |
Comparative analysis of different methodological approaches to the in vitro study of drug-induced apoptosis.
Topics: Annexin A5; Apoptosis; Cell Size; Cisplatin; DNA Fragmentation; Dose-Response Relationship, Drug; Etoposide; Evaluation Studies as Topic; Flow Cytometry; Fluorescein-5-isothiocyanate; HL-60 Cells; Humans; Leukemia, Promyelocytic, Acute; Light; Microscopy, Video; Scattering, Radiation; Time Factors | 1999 |
CpG-specific common commitment in caspase-dependent and -independent cell deaths.
Topics: Amino Acid Chloromethyl Ketones; Annexin A5; Apoptosis; Caspase Inhibitors; Caspases; Cell Line; CpG Islands; Cysteine Proteinase Inhibitors; DNA Fragmentation; Enzyme Inhibitors; Etoposide; fas Receptor; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Necrosis; Nucleic Acid Synthesis Inhibitors; Oligonucleotides; Phosphatidylserines; Time Factors; Tumor Cells, Cultured | 2000 |
The organization of replicon clusters is not affected by polyamine depletion.
Topics: Amanitins; Amidines; Animals; Antibodies, Monoclonal; Aphidicolin; Bromodeoxyuridine; CHO Cells; Cricetinae; DNA Replication; Eflornithine; Etoposide; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique; Indans; Microscopy, Confocal; Polyamines; Replicon; S Phase | 2000 |
Using CTLL-2 and CTLL-2 bcl2 cells to avoid interference by apoptosis in the in vitro micronucleus test.
Topics: Animals; Annexin A5; Apoptosis; Cells, Cultured; Dexamethasone; Etoposide; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Mice; Mice, Inbred C57BL; Micronucleus Tests; Mutagens; Proto-Oncogene Proteins c-bcl-2; Sensitivity and Specificity; T-Lymphocytes, Cytotoxic | 2003 |
Time dependent appearance of selected apoptotic markers and usefulness of their detection in vitro.
Topics: Actins; Annexin A5; Apoptosis; Biomarkers; Caspase 3; Caspases; Cell Division; Chromates; DNA Fragmentation; DNA, Neoplasm; Etoposide; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Melanoma, Experimental; Microscopy, Video; Phosphatidylserines; Potassium Compounds; Tumor Cells, Cultured | 2002 |
The C-terminal tail of the M3-muscarinic receptor possesses anti-apoptotic properties.
Topics: Amino Acid Sequence; Animals; Annexin A5; Apoptosis; Caspase 3; Caspases; CHO Cells; Cricetinae; DNA Damage; Enzyme Activation; Etoposide; Fluorescein-5-isothiocyanate; Fluorescent Dyes; GTP-Binding Protein alpha Subunits, Gq-G11; Heterotrimeric GTP-Binding Proteins; Humans; JNK Mitogen-Activated Protein Kinases; MAP Kinase Kinase 4; Microscopy, Fluorescence; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Molecular Sequence Data; Mutagenesis, Site-Directed; Peptide Fragments; Phosphorylation; Receptor, Muscarinic M3; Receptors, Muscarinic; Sequence Alignment; Signal Transduction; Structure-Activity Relationship; Transfection; Type C Phospholipases | 2003 |
Differences in the longevity of topo IIalpha and topo IIbeta drug-stabilized cleavable complexes and the relationship to drug sensitivity.
Topics: Amsacrine; Animals; Antigens, Neoplasm; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Neoplasm; Etoposide; Fibroblasts; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique; Fluorescent Dyes; Half-Life; Isoenzymes; Kinetics; Mice; Mitoxantrone | 2004 |
MDM2 is required for suppression of apoptosis by activated Akt1 in salivary acinar cells.
Topics: Animals; Apoptosis; Cells, Cultured; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Etoposide; Female; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Gamma Rays; Mice; Mice, Transgenic; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-mdm2; Salivary Glands; Transgenes | 2006 |
Lovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposide.
Topics: Antibiotics, Antineoplastic; Antimutagenic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Survival; DNA Damage; DNA Replication; Doxorubicin; Drug Resistance, Neoplasm; Endothelial Cells; Etoposide; Fibroblasts; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lovastatin; Reactive Oxygen Species; Reverse Transcriptase Polymerase Chain Reaction; Topoisomerase II Inhibitors | 2006 |
Cellular responses to etoposide: cell death despite cell cycle arrest and repair of DNA damage.
Topics: Annexins; Blotting, Western; Cell Cycle; Cell Death; DNA Breaks, Double-Stranded; DNA Damage; DNA Repair; Etoposide; Flow Cytometry; Fluorescein-5-isothiocyanate; HT29 Cells; Humans; Neoplasm Proteins; Propidium; Tumor Stem Cell Assay | 2010 |
Corneal endothelial cells are protected from apoptosis by gene therapy.
Topics: Apoptosis; bcl-X Protein; Cornea; Corneal Transplantation; Endothelial Cells; Etoposide; Flow Cytometry; Fluorescein-5-isothiocyanate; Gene Transfer Techniques; Genetic Therapy; Humans; Viral Proteins | 2011 |
Liposomal formulations of Etoposide and Docetaxel for p53 mediated enhanced cytotoxicity in lung cancer cell lines.
Topics: Annexin A5; beta-Galactosidase; Cell Death; Cell Line, Tumor; Chemistry, Pharmaceutical; Coumarins; Deoxyribonucleases; Docetaxel; Electrophoresis, Agar Gel; Electrophoretic Mobility Shift Assay; Etoposide; Flow Cytometry; Fluorescein-5-isothiocyanate; Freeze Drying; Humans; Intracellular Space; Liposomes; Lung Neoplasms; Microscopy, Electron, Transmission; Particle Size; Static Electricity; Taxoids; Transfection; Tumor Suppressor Protein p53 | 2012 |